4547.T
KISSEI PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 4,080.00
+0.37%Year over year
Reported trailing growth
- Revenue
- +10.3%
- EBITDA
- —
- EBIT
- —
- EPS
- +21.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -2.0%
- EBITDA
- —
- EPS
- -7.5%
Three-year CAGR
- Revenue
- +13.0%
- EBITDA
- -16.8%
- EBIT
- —
- Net income
- +9.4%
- EPS
- +13.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026